Seeking New Users for iSeq
The Changing Sequencing Landscape
Cell Therapy Manufacturing: All Signs Point to Commercialization
As Milestones Are Reached, Best Practices Will Become Less Hazy
Vaccine Industry Retools Itself for Speed
Vaccine Manufacturing Moves toward Mass Customization
Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017
15% Year-Over-Year Growth, with Sales Set to More than Double by 2022
For full access to this article login to GEN Select now.
Stem Cells Grapple with High Expectations
Hopes Are High, Yet Potential Pitfalls Abound as Research Wends Its Way through the Clinic
- The future may not exactly rest in the figurative hands of stem cells, but David Magnus, Ph.D., director at Stanford Center of Biomedical Ethics and professor of medicine and biomedical ethics, pediatrics at Stanford University, acknowledges that the stakes are high. “There are tremendous expectations of stem cell research ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.